23andMe receives NIH funding to evaluate web-based research on the genetics of drug response
Thursday, December 16, 2010 - 21:00
in Mathematics & Economics
23andMe has launched a project funded by the National Institutes of Health (NIH) which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.
